Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Director departure
Inv. presentation
Appointed director

Stereotaxis, Inc. (STXS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "Stereotaxis Reports 2023 Second Quarter Financial Results"
05/09/2023 8-K Quarterly results
Docs: "Stereotaxis Reports 2023 First Quarter Financial Results"
03/03/2023 8-K Quarterly results
Docs: "Stereotaxis Reports 2022 Full Year Financial Results"
11/10/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/03/2022 8-K Quarterly results
11/12/2021 8-K Quarterly results
Docs: "Stereotaxis Reports 2021 Third Quarter Financial Results"
05/10/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
11/09/2020 8-K Quarterly results
Docs: "Stereotaxis Reports 2020 Third Quarter Financial Results"
08/06/2020 8-K Quarterly results
05/05/2020 8-K Quarterly results
03/10/2020 8-K Quarterly results
11/14/2019 8-K Quarterly results
08/08/2019 8-K Quarterly results
05/09/2019 8-K Quarterly results
Docs: "Stereotaxis Reports 2019 First Quarter Financial & Operational Results ST. LOUIS, MO, May 9, 2019 – Stereotaxis , the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the first quarter ended March 31, 2019. In separate press releases issued concurrently with this release, Stereotaxis showcased for the first time a next-generation robotic system, a novel x-ray imaging system, and a development program for a proprietary robotically-navigated magnetic ablation catheter. “The start of 2019 is highlighted by significant innovation accomplishments across all key aspects of our technology,” said David Fischel, Chairman and CEO. “These innovations will positively impact patient care, the physician experience, and the br..."
03/12/2019 8-K Quarterly results
Docs: "Stereotaxis Reports 2018 Full Year Financial Results ● Record high annual recurring revenue of $27.8 million; 3% annual growth ● Positive annual net income for the first time in Company history despite significantly increased R&D investments ● Innovation initiatives to be showcased in May at Heart Rhythm Society meeting ● Strong financial position to reach profitability without the need for additional financings ● Conference call today at 10:00 a.m. Eastern Time ST. LOUIS, MO, March 12, 2019 – Stereotaxis, Inc. , the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the fourth quarter and full year ended December 31, 2018. “2018 was an extremely active year at Stereotaxis with progre..."
11/13/2018 8-K Quarterly results
Docs: "Stereotaxis Reports 2018 Third Quarter Financial Results ● Continued progress on strategic innovation initiatives; expect to showcase in 1H 2019 ● 4% recurring revenue growth; reaffirming 2018 record recurring revenue expectations ● Conference call today at 10:00 a.m. Eastern Time ST. LOUIS, MO, Nov. 12, 2018 – Stereotaxis, Inc. , the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the third quarter ended September 30, 2018. “We continue to make meaningful progress on our strategic innovation initiatives, and expect to be able to publicly showcase our progress in the first half of 2019,” said David Fischel, Chairman and CEO. “We are confident that our innovation strategy is clinically and comm..."
08/07/2018 8-K Quarterly results
Docs: "Stereotaxis Reports 2018 Second Quarter Financial Results ● Progress on strategic internal innovation and external collaborations ● Continued growth in recurring revenue ● Positive cash flow from operations ● Reaffirming 2018 expectations ● Conference call today at 10:00 a.m. Eastern Time ST. LOUIS, MO, Aug. 7, 2018 – Stereotaxis, Inc. , the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the second quarter ended June 30, 2018. “The second quarter was notable for the strategic agreements announced with Johnson & Johnson’ s Biosense Webster and with Acutus Medical. These agreements are important parts of our broader strategic innovation initiative, which continues to advance both in..."
05/14/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : May 14, 2018 STEREOTAXIS, INC. Delaware 001-36159 94-3120386 4320 Forest Park Avenue, Suite 100, St. Louis, Missouri 63108 678-6100",
"Stereotaxis Reports 2018 First Quarter Financial Results"
03/06/2018 8-K Quarterly results
Docs: "FORM 8-K",
"Form of Amended and Restated Warrant of Stereotaxis, Inc",
"Consent and Amendment, by and between Stereotaxis, Inc. and the holders identified on the signature pages thereto",
"Form of Lock-up Agreement between Stereotaxis, Inc. and the holders exercising the Amended and Restated Warrant",
"Stereotaxis Reports 2017 Fourth Quarter and Full Year Financial Results"
11/09/2017 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : November 9, 2017 STEREOTAXIS, INC. Delaware 001-36159 94-3120386 4320 Forest Park Avenue, Suite 100, St. Louis, Missouri 63108 678-6100",
"Stereotaxis Reports Third Quarter 2017 Financial Results"
08/10/2017 8-K Quarterly results
05/08/2017 8-K Form 8-K - Current report
11/07/2016 8-K Quarterly results
Docs: "Stereotaxis Reports 2016 Third Quarter Financial Results"
08/09/2016 8-K Form 8-K - Current report
05/09/2016 8-K Form 8-K - Current report
02/22/2016 8-K Quarterly results
Docs: "Stereotaxis Reports 2015 Fourth Quarter and Full Year Financial Results"
11/03/2015 8-K Quarterly results
Docs: "Stereotaxis Reports 2015 Third Quarter Financial Results"
08/04/2015 8-K Quarterly results
Docs: "Stereotaxis Reports 2015 Second Quarter Financial Results",
"Stereotaxis Reports 2015 Second Quarter Financial Results"
05/06/2015 8-K Quarterly results
Docs: "Stereotaxis Reports 2015 First Quarter Financial Results"
02/25/2015 8-K Quarterly results
Docs: "Stereotaxis Reports 2014 Fourth Quarter and Full Year Financial Results"
11/06/2014 8-K Quarterly results, Conference call transcript
Docs: "Stereotaxis Reports 2014 Third Quarter Financial Results",
"Stereotaxis, Inc. Script from the conference call on November 5, 2014"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy